Navigation Links
Building a stronger roof over your head: '3 little pigs' project begins first tests
Date:8/25/2008

LONDON, ON With hurricane season upon us, many wonder if the roof over their heads will hold firm in the face of high winds. This week, inaugural tests at The University of Western Ontario's 'Three Little Pigs' project at The Insurance Research Lab for Better Homes will begin to provide answers as researchers 'raze the roof'.

The Insurance Research Lab for Better Homes is the first of its kind in the world to subject full-scale houses to pressures that simulate the effects of winds as strong as a Category 5 hurricane or 200 mph all within a controlled environment. Researchers at the $7-million facility will also be studying the destructive pathways of mould and water.

As it is too expensive to engineer an entire house, researchers hope to make them safer through basic additions and amendments, with minimal cost to homeowners. Specifically, researchers will be watching the roof fail to see how load on the house redistributes. This will tell them how failure of the structure occurs and will help answer questions about the adequacy of building codes. Ultimately, different wind damage mitigation strategies and building products will be tested in the facility.

Enclosed in a large, blue steel hanger that can be moved on tracks, the test model is a 1,900 square foot, two-storey, four-bedroom house typical of homes found in southwestern Ontario. 60 pressure boxes used to simulate hurricane-force loads are rigged to a framework that surrounds the house.

These studies build on expertise developed through 40 years of wind tests at the Boundary Layer Wind Tunnel Laboratory at Western, widely regarded as one of the best wind tunnels in the world. The project is also affiliated with Fanshawe College, the Institute for Catastrophic Loss Reduction, Cambridge Consultants, Ltd. and Insurance Bureau of Canada.


'/>"/>

Contact: Douglas Keddy
dkeddy@uwo.ca
519-661-2111 x87485
University of Western Ontario
Source:Eurekalert

Page: 1

Related biology news :

1. Building blocks of life
2. Rebuilding the evolutionary history of HIV-1 unravels a complex loop
3. Building blocks of life formed on Mars
4. Building disease-beating wheat
5. Building the future -- 21st century nano tools to repair the nervous system
6. International workshop to address capacity building for rainforest leaders
7. In Todays Economy, You Can Strengthen Your Company by Building Your Brand
8. Scientists make chemical cousin of DNA for use as new nanotechnology building block
9. UCI awarded $27.2 million for new stem cell building
10. Building on pyramids of trash
11. Manchester clears first hurdle in €170 million biobank building boom
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... Van Andel Research Institute (VARI) researchers have determined precisely ... molecular level to help plants respond to environmental stresses such ... journal Nature , could help engineer crops that thrive ... shortages. The findings could also have implications for stress ...
(Date:12/3/2009)... measured CO2 levels for the past three years in ... area near Valladolid. The results, which are the first ... the levels rose "significantly" between 2002 and 2005. , ... to find out about carbon dioxide (CO2) levels, and ...
(Date:12/2/2009)... cigarette smoke have an increased risk of developing lung cancer ... of this study are published in Cancer Epidemiology, Biomarkers ... Cancer Research, as part of a special tobacco focus in ... 219,000 Americans will be diagnosed with lung cancer; more than ...
Breaking Biology News(10 mins):VAI researchers find long awaited key to creating drought resistant crops 2VAI researchers find long awaited key to creating drought resistant crops 3CO2 levels rising in troposphere over rural areas 2Secondhand smoke exposure in childhood increases lung cancer risk later in life 2Youth Find Innovative Solutions to Leading Health Threat 54050 1Youth Find Innovative Solutions to Leading Health Threat 54050 2Youth Find Innovative Solutions to Leading Health Threat 54050 3Youth Find Innovative Solutions to Leading Health Threat 54050 4McKesson Expands Pharmacy Automation Product Portfolio to Include I V Therapy 13473 1McKesson Expands Pharmacy Automation Product Portfolio to Include I V Therapy 13473 2McKesson Expands Pharmacy Automation Product Portfolio to Include I V Therapy 13473 3Eiger BioPharmaceuticals Announces Initiation of CLEAN 1 HCV Phase 1b Trial 4840 1Eiger BioPharmaceuticals Announces Initiation of CLEAN 1 HCV Phase 1b Trial 4840 2Eiger BioPharmaceuticals Announces Initiation of CLEAN 1 HCV Phase 1b Trial 4840 3
... being used in animal models ?to treat cancer by disrupting ... of Medicine completed a study in mice in which they ... then to treat it with a continuous wave of low-level ... to what is used in physiotherapy ultrasound (about 2.5 watts), ...
... in Current Biology, tsunami damage to coral reefs closest ... occasionally spectacular, but surprisingly limited, particularly when compared to ... , Less than 100 days after the tsunami of ... Cook University, the Wildlife Conservation Society-Indonesia Program, and Syiah ...
... light a mechanism that regulates the way an internal ... divide, according to a report in Science Express. , ... , and his colleagues at Yale study Trypanosoma brucei, ... it is exceptionally streamlined and has only one of ...
Other Biology News:Penn researchers study the use of ultrasound for treatment of cancer 2Sleeping sickness parasite shows how cells divide their insides 2
(Date:12/2/2009)... YORK, Dec. 2 Reportlinker.com announces that ... in its catalogue: ,, Drug Discovery ... Trends & Opportunities ,, http://www.reportlinker.com/p0164246/Drug-Discovery-Technologies---A-Global-Update-of-Market-Trends--Opportunities.html ... integral and ongoing element of every pharmaceutical ...
(Date:12/2/2009)... 2 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) ... confirmation and dosimetry trial of Cotara® in patients with ... cancer. Cotara is a targeted monoclonal antibody linked ... treatment for GBM. Cotara specifically targets cells at ...
(Date:12/2/2009)... Pepscan Holding NV,the Netherlands based biotechnology company focusing on ... announced that it,has appointed Wim E.M. Mol, Ph.D. as ... Dr. Mol will be responsible for all of Pepscans ... the company. He brings to,Pepscan more than 20 years ...
(Date:12/2/2009)... announced data presentations on its novel oral JAK2 inhibitor, ... Meeting and Exposition in New Orleans. ,, Data will ... 1 dose-escalation trial of SB1518 detailing its safety, tolerability ... 100 to 600 mg. These doses were administered once ...
Breaking Biology Technology:Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Dutch Biotech Company Pepscan Appoints New CEO 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5
... NORWALK, Conn., Oct. 22 Dr. Cindy Dennison ... Briefing, a daily,news service for health and medical ... the leading role in managing,Physician,s Briefing,s editing and ... the professional news service and,HealthDay, a leading daily ...
... Aida,Pharmaceuticals, Inc. (OTC Bulletin Board: AIDA) today announced ... product to be launched by,the Company into the China ... Phase I tests in July 2006, which consists of ... be tested in,Phases II & III. Aida is currently ...
... Oct. 22 Blood Systems intends to,purchase ... Analyzers for,the organization,s 21 component production/quality control ... Vice President for,Manufacturing Systems Dennis Harpool. Quality ... testing will be performed using,the Sysmex XE-2100D ...
Other Biology Technology:Cynthia Haines, M.D., Named Managing Editor of Physician's Briefing News Wire 2Aida's Rh-Apo2L Clinical Testing Shows Preliminary Efficacy in Helping to Treat Lung Cancer, Stomach Cancer, Lymphoma, Pancreatic Cancer & Kidney Cancer 2Aida's Rh-Apo2L Clinical Testing Shows Preliminary Efficacy in Helping to Treat Lung Cancer, Stomach Cancer, Lymphoma, Pancreatic Cancer & Kidney Cancer 3One of Nation's Oldest Blood Services Providers Turns to Sysmex America 2One of Nation's Oldest Blood Services Providers Turns to Sysmex America 3
...
...
DryStrip aligners, 4. Category: Electrophoresis Systems & Standards & Reagents, IEF & SDS-PAGE & 2-D Electrophoresis, Multiphor II Kits & Components and Accessories....
Newborn Calf Serum US Origin...
Biology Products: